$2.28T
Total marketcap
$374.26B
Total volume
BTC 55.55%     ETH 9.32%
Dominance

Elekta AB (publ) EKTAF Stock

$6.50   0.000000%
Add to favorites
Market Cap
$2.48B
LOW - HIGH [24H]
$6.50 - $6.50
VOLUME [24H]
$1.34K
P/E Ratio
0
Earnings per share
-$0.15
ISIN
SE0000163628
Price   Prediction

Elekta AB (publ) Price Chart

Sorry, that's all we've gotfor now...

Elekta AB (publ) EKTAF Financial and Trading Overview

Elekta AB (publ) stock price 6.5 USD
Previous Close 6.5 USD
Open 6.5 USD
Bid 5.45 USD x 80000
Ask 6.03 USD x 10000
Day's Range 6.5 - 6.5 USD
52 Week Range 4.48 - 6.83 USD
Volume 1.34K USD
Avg. Volume 52 USD
Market Cap 2.48B USD
Beta (5Y Monthly) 0.963
PE Ratio (TTM) N/A
EPS (TTM) -0.15 USD
Forward Dividend & Yield 0.26 (4.01%)
Ex-Dividend Date March 5, 2026
1y Target Est N/A

EKTAF Valuation Measures

Enterprise Value N/A
Trailing P/E N/A
Forward P/E 1.3052208
PEG Ratio (5 yr expected) 0.31
Price/Sales (ttm) N/A
Price/Book (mrq) 0.29394472
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Elekta AB (publ) Stock Price History

Beta (5Y Monthly) 0.963
52-Week Change 20.37%
S&P500 52-Week Change 27.69%
52 Week High 6.83 USD
52 Week Low 4.48 USD
50-Day Moving Average 6.21 USD
200-Day Moving Average 5.76 USD

EKTAF Share Statistics

Avg. Volume (3 month) 52 USD
Avg. Daily Volume (10-Days) 300 USD
Shares Outstanding 367.1M
Float 318.7M
Short Ratio N/A
% Held by Insiders 1.92%
% Held by Institutions 66.92%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield 333.00%
Payout Ratio 3.1579
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends April 30, 2026
Most Recent Quarter (mrq) April 30, 2026
Next Fiscal Year End April 30, 2027

Profitability

Profit Margin -3.10%
Operating Margin (ttm) 0%
Gross Margin 38.38%
EBITDA Margin 8.57%

Management Effectiveness

Return on Assets (ttm) 2.48%
Return on Equity (ttm) -6.45%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) -7.59%
Gross Profit (ttm) N/A
EBITDA 1.43B USD
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) -0.15
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) 102.56 USD
Current Ratio (mrq) 0.87
Book Value Per Share (mrq) 22.113

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) 1.12B USD

Profile of Elekta AB (publ)

Country United States
State N/A
City Stockholm
Address Hagaplan 4
ZIP 113 68
Phone 46 8 58 72 54 00
Website https://www.elekta.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 4353

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as well as quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit, a gamma knife system; and Leksell GammaPlan, a treatment planning and management software, as well as Elekta ONE, an oncology software suite. In addition, the company offers brachytherapy products, including Elekta Studio, an image-guided brachytherapy solution; ImagingRing for dynamic imaging; Oncentra Brachy, a smart tool that facilitates repetitive tasks; Elekta Xoft Axxent and electronic brachytherapy systems; Elekta Geneva, an applicator for cervical cancer patients; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Venezia applicator that enables the oncologist to treat locally advanced cervical cancer. Further, it provides Leksell Vantage Stereotactic System, a neurosurgery product; Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. Additionally, the company offers Elekta Care support services; Elekta Care 360, which provides a range of clinical and professional services; Elekta Care Learning that offers in-person and digital training courses on radiotherapy; Elekta Care Community, a self-help center; Elekta Partner Community, an online self-service portal; and Elekta Intellimax for predictive maintenance. Elekta AB (publ) was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Q&A For Elekta AB (publ) Stock

What is a current EKTAF stock price?

Elekta AB (publ) EKTAF stock price today per share is 6.5 USD.

How to purchase Elekta AB (publ) stock?

You can buy EKTAF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Elekta AB (publ)?

The stock symbol or ticker of Elekta AB (publ) is EKTAF.

Which industry does the Elekta AB (publ) company belong to?

The Elekta AB (publ) industry is Medical Devices.

How many shares does Elekta AB (publ) have in circulation?

The max supply of Elekta AB (publ) shares is 382.08M.

What is Elekta AB (publ) Price to Earnings Ratio (PE Ratio)?

Elekta AB (publ) PE Ratio is now.

What was Elekta AB (publ) earnings per share over the trailing 12 months (TTM)?

Elekta AB (publ) EPS is -0.15 USD over the trailing 12 months.

Which sector does the Elekta AB (publ) company belong to?

The Elekta AB (publ) sector is Healthcare.

Select currency